Albert “Skip” Rizzo, Ph.D., is an internationally recognized clinical psychologist and neuropsychologist who founded one of the world’s first Clinical Virtual Reality laboratories at USC in 1995 and currently serves as Director of Medical VR at the USC Institute for Creative Technologies, where he has spent three decades designing, developing, and evaluating over 60 VR and Virtual Human systems for clinical diagnosis, treatment, and research across domains such as PTSD, anxiety, depression, autism, ADHD, stroke, traumatic brain injury, cerebral palsy, and other health conditions; best known for his groundbreaking BRAVEMIND PTSD therapy used with veterans and trauma survivors, he has collaborated extensively with computer scientists, engineers, artists, and medical leaders to advance the field, earning widespread recognition including being named one of Polygon’s top 25 VR innovators, Ozy’s “Godfather of Virtual Reality,” recipient of the 2018 Michael Dell “Engine of Human Progress” award, the ISTSS Trauma Innovation Award, the International Society on Virtual Rehabilitation Distinguished Service Award, the Best Paper Award for his VR ADHD classroom study involving 700 children, and the 2023 IEEE VR Lifetime Achievement Award; his team also secured second place and $1M funding in the VA Mission Daybreak competition for the Battle Buddy suicide-prevention system, while his career research portfolio exceeds $60M in funding—$30M specifically in Virtual Humans—with major grants from the Department of Defense, DARPA, VA, Army Research Lab, and leading industry partners including HP, Nvidia, Google, Dell, Intel, Samsung, HTC/Valve, AMD, Magic Leap, and many others; with more than 350 peer-reviewed publications, 31 chapters, 10 books, over 1000 professional presentations, 41 awards, and over 1000 media appearances, Dr. Rizzo’s influential body of work continues to shape and expand the global impact of clinical VR in healthcare and rehabilitation.